ASRT - Assertio Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ASRT is currently covered by 2 analysts with an average price target of $9.56. This is a potential upside of $7.9 (475.9%) from yesterday's end of day stock price of $1.66.

Assertio Therapeutics's activity chart (see below) currently has 54 price targets and 40 ratings on display. The stock rating distribution of ASRT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.61% with an average time for these price targets to be met of 118.1 days.

Highest price target for ASRT is $4, Lowest price target is $4, average price target is $9.56.

Most recent stock forecast was given by THOMAS FLATEN from LAKE STREET on 04-Jan-2024. First documented stock forecast 16-Jan-2015.

Currently out of the existing stock ratings of ASRT, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4

$2.34 (140.96%)

4

6 months 11 days ago

1/5 (20%)

$3.1 (344.44%)

184

Buy

4

$2.34 (140.96%)

6

8 months 12 days ago

1/5 (20%)

$1.66 (70.94%)

289

Hold

16

$14.89 (1341.44%)

52

4 years 11 months 7 days ago

1/5 (20%)

$4.76 (42.35%)

59

Hold

12

$9.09 (312.37%)

28

5 years 1 months 29 days ago

9/12 (75%)

$5.34 (9.39%)

50

Buy

40

5 years 10 months 16 days ago

1/9 (11.11%)

$6.64 (19.90%)

120

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ASRT (Assertio Therapeutics) average time for price targets to be met?

On average it took 118.1 days on average for the stock forecasts to be realized with a an average price target met ratio 54.61

Which analyst has the current highest performing score on ASRT (Assertio Therapeutics) with a proven track record?

AMI FADIA

Which analyst has the most public recommendations on ASRT (Assertio Therapeutics)?

Ami Fadia works at NEEDHAM and has 7 price targets and 4 ratings on ASRT

Which analyst is the currently most bullish on ASRT (Assertio Therapeutics)?

Scott Henry with highest potential upside - $112.89

Which analyst is the currently most reserved on ASRT (Assertio Therapeutics)?

Ken Trbovich with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?